

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, classical pathway (GO:0006958) | 9.24854042 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 8.31063724 |
| 3 | complement activation (GO:0006956) | 7.37544088 |
| 4 | glomerular filtration (GO:0003094) | 6.98020570 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.54172635 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.44328800 |
| 7 | renal filtration (GO:0097205) | 6.27373494 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.22813388 |
| 9 | regulation of respiratory burst (GO:0060263) | 5.57101300 |
| 10 | protein activation cascade (GO:0072376) | 5.42225030 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03751622 |
| 12 | antibacterial humoral response (GO:0019731) | 5.00492456 |
| 13 | antimicrobial humoral response (GO:0019730) | 4.93529390 |
| 14 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 4.80863854 |
| 15 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 4.80863854 |
| 16 | Fc-gamma receptor signaling pathway (GO:0038094) | 4.80863854 |
| 17 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 4.78855987 |
| 18 | humoral immune response (GO:0006959) | 4.58489269 |
| 19 | regulation of cellular extravasation (GO:0002691) | 4.50899359 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.50554073 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.50554073 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.25223201 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.00099711 |
| 24 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.91060306 |
| 25 | detection of bacterium (GO:0016045) | 3.90545088 |
| 26 | detection of other organism (GO:0098543) | 3.81843905 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.78671259 |
| 28 | type I interferon signaling pathway (GO:0060337) | 3.76753865 |
| 29 | cellular response to type I interferon (GO:0071357) | 3.76753865 |
| 30 | response to type I interferon (GO:0034340) | 3.74123450 |
| 31 | retina homeostasis (GO:0001895) | 3.73303903 |
| 32 | germinal center formation (GO:0002467) | 3.53690831 |
| 33 | regulation of antigen processing and presentation (GO:0002577) | 3.46261262 |
| 34 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.34993351 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.34640767 |
| 36 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.30743889 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28884164 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.28748292 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.28748292 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 3.28748292 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.28748292 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 3.28748292 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.28748292 |
| 44 | chronic inflammatory response (GO:0002544) | 3.24698776 |
| 45 | B cell mediated immunity (GO:0019724) | 3.23307864 |
| 46 | cellular response to interferon-gamma (GO:0071346) | 3.20892328 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.18054662 |
| 48 | angiotensin maturation (GO:0002003) | 3.16595400 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.15092142 |
| 50 | positive regulation of pseudopodium assembly (GO:0031274) | 3.14655135 |
| 51 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.14527259 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09298391 |
| 53 | response to interferon-gamma (GO:0034341) | 3.02551594 |
| 54 | eosinophil chemotaxis (GO:0048245) | 3.01009291 |
| 55 | B cell receptor signaling pathway (GO:0050853) | 2.98767124 |
| 56 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.95703748 |
| 57 | regulation of T cell tolerance induction (GO:0002664) | 2.91497818 |
| 58 | dendritic cell chemotaxis (GO:0002407) | 2.90786497 |
| 59 | production of molecular mediator of immune response (GO:0002440) | 2.90212244 |
| 60 | detection of external biotic stimulus (GO:0098581) | 2.87274373 |
| 61 | respiratory burst (GO:0045730) | 2.86861431 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 2.85035739 |
| 63 | regulation of integrin activation (GO:0033623) | 2.84086909 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80765105 |
| 65 | regulation of gamma-delta T cell activation (GO:0046643) | 2.80555411 |
| 66 | regulation of pseudopodium assembly (GO:0031272) | 2.80192235 |
| 67 | macrophage activation involved in immune response (GO:0002281) | 2.80106475 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79167550 |
| 69 | negative regulation of myotube differentiation (GO:0010832) | 2.75583353 |
| 70 | interferon-gamma secretion (GO:0072643) | 2.73425219 |
| 71 | T-helper 1 type immune response (GO:0042088) | 2.71563049 |
| 72 | eosinophil migration (GO:0072677) | 2.70521008 |
| 73 | T cell costimulation (GO:0031295) | 2.66009907 |
| 74 | immune response-activating signal transduction (GO:0002757) | 2.65644487 |
| 75 | defense response to Gram-negative bacterium (GO:0050829) | 2.65232941 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 2.63888309 |
| 77 | GDP-mannose metabolic process (GO:0019673) | 2.62761009 |
| 78 | lymphocyte costimulation (GO:0031294) | 2.62111555 |
| 79 | regulation of tolerance induction (GO:0002643) | 2.57957632 |
| 80 | activation of immune response (GO:0002253) | 2.57826534 |
| 81 | dendritic cell migration (GO:0036336) | 2.56315748 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 2.55990229 |
| 83 | regulation of guanylate cyclase activity (GO:0031282) | 2.53587256 |
| 84 | response to interleukin-15 (GO:0070672) | 2.48024848 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.47960719 |
| 86 | peptide catabolic process (GO:0043171) | 2.47820532 |
| 87 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.47464734 |
| 88 | oligosaccharide biosynthetic process (GO:0009312) | 2.47223187 |
| 89 | negative regulation of innate immune response (GO:0045824) | 2.43684265 |
| 90 | regulation of regulatory T cell differentiation (GO:0045589) | 2.43592817 |
| 91 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.42609870 |
| 92 | positive regulation of type 2 immune response (GO:0002830) | 2.41992799 |
| 93 | positive thymic T cell selection (GO:0045059) | 2.40295200 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.39594626 |
| 95 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.39419271 |
| 96 | positive regulation of T cell migration (GO:2000406) | 2.38439820 |
| 97 | intestinal absorption (GO:0050892) | 2.37641724 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 2.37208622 |
| 99 | defense response to protozoan (GO:0042832) | 2.36798889 |
| 100 | epithelial structure maintenance (GO:0010669) | 2.36771053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.20618955 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.01972566 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.87542099 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.25912656 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.18664127 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.80845438 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.70272308 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46759201 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.38344121 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34916119 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31379586 |
| 12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.28435432 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.27509876 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22866539 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17058886 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12419669 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.11410908 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93309454 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90142350 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89776547 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84709871 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84629549 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82209415 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78308347 |
| 25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.75456705 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74324798 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72813627 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69869050 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68905860 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63745720 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62216063 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.58965383 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.56721390 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.50937691 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.47352626 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46782199 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46364927 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43712604 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43695729 |
| 40 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.42819714 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40273236 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39540426 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39180348 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38751758 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.38107119 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.36816225 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36627523 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35217001 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.34954444 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33554680 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32285223 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30750253 |
| 53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28508584 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28298798 |
| 55 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27625341 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26632847 |
| 57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.25809170 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25070620 |
| 59 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24822430 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23703788 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22635461 |
| 62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17482457 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15701843 |
| 64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14495864 |
| 65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14310440 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13804356 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12364931 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12254316 |
| 69 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11251659 |
| 70 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10917499 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09891633 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09174210 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06328602 |
| 74 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05448698 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04538451 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04361331 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03759629 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03358047 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03088115 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02577560 |
| 81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01712045 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98926115 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98866242 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98127891 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97702590 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96326632 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96218801 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93608757 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92805086 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 0.90573998 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90456127 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89594221 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89503876 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88890015 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86639351 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86110538 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86070152 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85850088 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85516313 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85164073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.29676233 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.54293390 |
| 3 | MP0003303_peritoneal_inflammation | 3.52687038 |
| 4 | MP0001790_abnormal_immune_system | 3.23158738 |
| 5 | MP0005387_immune_system_phenotype | 3.23158738 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.18262833 |
| 7 | MP0010155_abnormal_intestine_physiology | 3.16360271 |
| 8 | MP0003436_decreased_susceptibility_to | 3.13250858 |
| 9 | MP0001800_abnormal_humoral_immune | 2.72485309 |
| 10 | MP0005671_abnormal_response_to | 2.61813234 |
| 11 | MP0005025_abnormal_response_to | 2.58882667 |
| 12 | MP0000685_abnormal_immune_system | 2.51038473 |
| 13 | MP0009785_altered_susceptibility_to | 2.42246997 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.41304374 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.25537928 |
| 16 | MP0003866_abnormal_defecation | 2.24922425 |
| 17 | MP0005166_decreased_susceptibility_to | 2.15649322 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.13666202 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.11942626 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.10943648 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.07092564 |
| 22 | MP0001873_stomach_inflammation | 2.06643471 |
| 23 | MP0004858_abnormal_nervous_system | 2.04277336 |
| 24 | MP0002723_abnormal_immune_serum | 2.03204020 |
| 25 | MP0002419_abnormal_innate_immunity | 2.01931740 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.99410053 |
| 27 | MP0001819_abnormal_immune_cell | 1.96524894 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.95252415 |
| 29 | MP0006082_CNS_inflammation | 1.86464744 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.85488789 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.80269488 |
| 32 | MP0004782_abnormal_surfactant_physiolog | 1.79292710 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.78726728 |
| 34 | MP0004947_skin_inflammation | 1.72694258 |
| 35 | MP0002139_abnormal_hepatobiliary_system | 1.70367079 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.69834878 |
| 37 | MP0001663_abnormal_digestive_system | 1.63794734 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.52233661 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.51678225 |
| 40 | MP0005310_abnormal_salivary_gland | 1.50364993 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.49178910 |
| 42 | MP0000716_abnormal_immune_system | 1.41342540 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.39933821 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.37677085 |
| 45 | MP0000490_abnormal_crypts_of | 1.35177845 |
| 46 | MP0003075_altered_response_to | 1.34852376 |
| 47 | MP0002398_abnormal_bone_marrow | 1.32764611 |
| 48 | MP0008004_abnormal_stomach_pH | 1.27484198 |
| 49 | MP0003448_altered_tumor_morphology | 1.26915391 |
| 50 | MP0002006_tumorigenesis | 1.24542052 |
| 51 | MP0002405_respiratory_system_inflammati | 1.23802347 |
| 52 | MP0000477_abnormal_intestine_morphology | 1.23668819 |
| 53 | MP0005360_urolithiasis | 1.23625227 |
| 54 | MP0005381_digestive/alimentary_phenotyp | 1.22060359 |
| 55 | MP0000604_amyloidosis | 1.22046415 |
| 56 | MP0005085_abnormal_gallbladder_physiolo | 1.21954621 |
| 57 | MP0005275_abnormal_skin_tensile | 1.21936482 |
| 58 | MP0003329_amyloid_beta_deposits | 1.18984829 |
| 59 | MP0001666_abnormal_nutrient_absorption | 1.18637919 |
| 60 | MP0002933_joint_inflammation | 1.18184847 |
| 61 | MP0000343_altered_response_to | 1.16624046 |
| 62 | MP0001664_abnormal_digestion | 1.15694730 |
| 63 | MP0005023_abnormal_wound_healing | 1.15424376 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.13883823 |
| 65 | MP0008469_abnormal_protein_level | 1.13717074 |
| 66 | MP0002429_abnormal_blood_cell | 1.11131797 |
| 67 | MP0003045_fibrosis | 1.07149500 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 1.06053675 |
| 69 | MP0000858_altered_metastatic_potential | 1.04783877 |
| 70 | MP0009840_abnormal_foam_cell | 1.04622370 |
| 71 | MP0003279_aneurysm | 1.03193139 |
| 72 | MP0002876_abnormal_thyroid_physiology | 1.00329073 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.00223322 |
| 74 | MP0009764_decreased_sensitivity_to | 0.97791221 |
| 75 | MP0002722_abnormal_immune_system | 0.97634596 |
| 76 | MP0005451_abnormal_body_composition | 0.94412367 |
| 77 | MP0005390_skeleton_phenotype | 0.93682072 |
| 78 | MP0000249_abnormal_blood_vessel | 0.91808128 |
| 79 | MP0001851_eye_inflammation | 0.88915144 |
| 80 | MP0004510_myositis | 0.85129925 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.84295681 |
| 82 | MP0005164_abnormal_response_to | 0.83814572 |
| 83 | MP0005365_abnormal_bile_salt | 0.82077561 |
| 84 | MP0009379_abnormal_foot_pigmentation | 0.81909946 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.80490646 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.79073767 |
| 87 | MP0005165_increased_susceptibility_to | 0.76387997 |
| 88 | MP0005388_respiratory_system_phenotype | 0.76172608 |
| 89 | MP0002133_abnormal_respiratory_system | 0.76172608 |
| 90 | MP0005409_darkened_coat_color | 0.75763841 |
| 91 | MP0002796_impaired_skin_barrier | 0.74978003 |
| 92 | MP0003091_abnormal_cell_migration | 0.74885845 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.74169079 |
| 94 | MP0003828_pulmonary_edema | 0.74028119 |
| 95 | MP0003252_abnormal_bile_duct | 0.74008978 |
| 96 | MP0003795_abnormal_bone_structure | 0.73347107 |
| 97 | MP0003868_abnormal_feces_composition | 0.71906647 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.69862287 |
| 99 | MP0005503_abnormal_tendon_morphology | 0.68039682 |
| 100 | MP0000681_abnormal_thyroid_gland | 0.67489176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.58017137 |
| 2 | Abnormality of macrophages (HP:0004311) | 5.27382497 |
| 3 | Prostate neoplasm (HP:0100787) | 5.20084439 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.93865068 |
| 5 | Agammaglobulinemia (HP:0004432) | 4.29548202 |
| 6 | Malnutrition (HP:0004395) | 4.27711042 |
| 7 | Vasculitis (HP:0002633) | 4.20831266 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.02583747 |
| 9 | Gastrointestinal stroma tumor (HP:0100723) | 3.97315980 |
| 10 | Abnormality of the prostate (HP:0008775) | 3.87397304 |
| 11 | Colitis (HP:0002583) | 3.74326774 |
| 12 | Cellulitis (HP:0100658) | 3.62036719 |
| 13 | Meningitis (HP:0001287) | 3.59332185 |
| 14 | Abnormality of complement system (HP:0005339) | 3.50271005 |
| 15 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.48514656 |
| 16 | Glomerulonephritis (HP:0000099) | 3.45054736 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.43919395 |
| 18 | Inflammation of the large intestine (HP:0002037) | 3.35402194 |
| 19 | Abnormality of B cell number (HP:0010975) | 3.33235218 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.31227025 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.26796932 |
| 22 | Complement deficiency (HP:0004431) | 3.23252072 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.21995636 |
| 24 | Skin rash (HP:0000988) | 3.20174105 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.16021524 |
| 26 | Recurrent sinusitis (HP:0011108) | 3.15026826 |
| 27 | Premature loss of primary teeth (HP:0006323) | 3.14721083 |
| 28 | Osteomyelitis (HP:0002754) | 3.14275602 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03842992 |
| 30 | Leukocytosis (HP:0001974) | 2.96432655 |
| 31 | Emphysema (HP:0002097) | 2.92590183 |
| 32 | Hyperactive renin-angiotensin system (HP:0000841) | 2.91803646 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 2.91033109 |
| 34 | Myositis (HP:0100614) | 2.88590405 |
| 35 | Increased IgE level (HP:0003212) | 2.87489341 |
| 36 | Orchitis (HP:0100796) | 2.87217278 |
| 37 | Urticaria (HP:0001025) | 2.85916648 |
| 38 | Nephritis (HP:0000123) | 2.85080001 |
| 39 | Chronic diarrhea (HP:0002028) | 2.84668040 |
| 40 | B lymphocytopenia (HP:0010976) | 2.84305326 |
| 41 | Recurrent viral infections (HP:0004429) | 2.84140618 |
| 42 | Chronic otitis media (HP:0000389) | 2.82865309 |
| 43 | Recurrent pneumonia (HP:0006532) | 2.81877118 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.79948534 |
| 45 | Gingivitis (HP:0000230) | 2.75809183 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75094073 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72277046 |
| 48 | Obstructive lung disease (HP:0006536) | 2.72277046 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66706371 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.64783621 |
| 51 | Hemoptysis (HP:0002105) | 2.62590722 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.54599537 |
| 53 | Recurrent lower respiratory tract infections (HP:0002783) | 2.48200117 |
| 54 | Villous atrophy (HP:0011473) | 2.47423541 |
| 55 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.47423541 |
| 56 | Bronchitis (HP:0012387) | 2.45855796 |
| 57 | Decreased circulating renin level (HP:0003351) | 2.44992080 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.41838367 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.39914237 |
| 60 | Optic neuritis (HP:0100653) | 2.39689639 |
| 61 | Retrobulbar optic neuritis (HP:0100654) | 2.39689639 |
| 62 | Abnormality of male internal genitalia (HP:0000022) | 2.38137374 |
| 63 | Verrucae (HP:0200043) | 2.36591631 |
| 64 | Papilloma (HP:0012740) | 2.36591631 |
| 65 | Lymphopenia (HP:0001888) | 2.33677111 |
| 66 | Restrictive lung disease (HP:0002091) | 2.32081065 |
| 67 | Recurrent skin infections (HP:0001581) | 2.31359195 |
| 68 | Increased IgM level (HP:0003496) | 2.28844440 |
| 69 | IgM deficiency (HP:0002850) | 2.27551043 |
| 70 | Pustule (HP:0200039) | 2.26120680 |
| 71 | Nasal polyposis (HP:0100582) | 2.25286167 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.18677485 |
| 73 | Purpura (HP:0000979) | 2.17822613 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.16902457 |
| 75 | Chest pain (HP:0100749) | 2.15280719 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.12767273 |
| 77 | Skin ulcer (HP:0200042) | 2.12463509 |
| 78 | Metabolic alkalosis (HP:0200114) | 2.10601644 |
| 79 | Encephalitis (HP:0002383) | 2.10407967 |
| 80 | Sepsis (HP:0100806) | 2.08849047 |
| 81 | Flat acetabular roof (HP:0003180) | 2.08575126 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08148636 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08148636 |
| 84 | Alkalosis (HP:0001948) | 2.07604924 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.03781914 |
| 86 | Neoplasm of the lung (HP:0100526) | 2.02599649 |
| 87 | Right ventricular cardiomyopathy (HP:0011663) | 2.01375387 |
| 88 | Hematochezia (HP:0002573) | 2.01229300 |
| 89 | IgA deficiency (HP:0002720) | 1.99823860 |
| 90 | Abnormality of T cells (HP:0002843) | 1.98153963 |
| 91 | Polycythemia (HP:0001901) | 1.97627899 |
| 92 | Ileus (HP:0002595) | 1.96181636 |
| 93 | Gingival bleeding (HP:0000225) | 1.95921803 |
| 94 | Keratoconjunctivitis sicca (HP:0001097) | 1.95828007 |
| 95 | Abnormality of renin-angiotensin system (HP:0000847) | 1.95822912 |
| 96 | Abnormality of the pleura (HP:0002103) | 1.95496307 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 1.94435907 |
| 98 | Hypermelanotic macule (HP:0001034) | 1.93986529 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 1.91617276 |
| 100 | Panhypogammaglobulinemia (HP:0003139) | 1.91141507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.82281767 |
| 2 | MAP4K1 | 3.74514892 |
| 3 | RIPK4 | 3.31833205 |
| 4 | TYK2 | 3.11451127 |
| 5 | PRPF4B | 3.08792785 |
| 6 | MST1R | 2.94468628 |
| 7 | FGFR4 | 2.77998164 |
| 8 | BLK | 2.43236939 |
| 9 | RIPK1 | 2.22989379 |
| 10 | EPHB1 | 2.14984645 |
| 11 | EPHA3 | 2.08339906 |
| 12 | JAK1 | 1.86331101 |
| 13 | KIT | 1.85913063 |
| 14 | JAK3 | 1.81993541 |
| 15 | CSK | 1.81685962 |
| 16 | IKBKE | 1.80730920 |
| 17 | MAP3K14 | 1.74280241 |
| 18 | CDC42BPA | 1.71479304 |
| 19 | ZAP70 | 1.70341145 |
| 20 | IRAK4 | 1.67621816 |
| 21 | PIK3CA | 1.63914629 |
| 22 | FGFR3 | 1.53395596 |
| 23 | GRK6 | 1.50725714 |
| 24 | TBK1 | 1.43472440 |
| 25 | SYK | 1.43302629 |
| 26 | FES | 1.41487363 |
| 27 | MAP3K1 | 1.36219141 |
| 28 | EPHA2 | 1.35266756 |
| 29 | MAP3K10 | 1.34203360 |
| 30 | LYN | 1.30409452 |
| 31 | JAK2 | 1.30169874 |
| 32 | MATK | 1.25282058 |
| 33 | ACVR1B | 1.22711750 |
| 34 | TXK | 1.18115123 |
| 35 | PRKG2 | 1.16801072 |
| 36 | BTK | 1.16458491 |
| 37 | STK24 | 1.15435868 |
| 38 | MAP3K13 | 1.15252460 |
| 39 | EPHB2 | 1.11738598 |
| 40 | CSF1R | 1.10897919 |
| 41 | SIK3 | 1.10345283 |
| 42 | TRIB3 | 1.07950201 |
| 43 | PTK6 | 1.06890082 |
| 44 | DDR2 | 1.05926747 |
| 45 | HCK | 1.05597063 |
| 46 | TAOK1 | 1.01204931 |
| 47 | MAP2K3 | 0.98341877 |
| 48 | MAP3K3 | 0.93452478 |
| 49 | PDGFRA | 0.92003604 |
| 50 | TGFBR2 | 0.89896055 |
| 51 | YES1 | 0.89573173 |
| 52 | IRAK1 | 0.89040284 |
| 53 | KSR2 | 0.87224937 |
| 54 | NLK | 0.86364948 |
| 55 | BMPR2 | 0.85780812 |
| 56 | FGR | 0.83612458 |
| 57 | LCK | 0.83262382 |
| 58 | MET | 0.75629702 |
| 59 | TESK2 | 0.75074582 |
| 60 | PDPK1 | 0.73722266 |
| 61 | MAP3K11 | 0.72130098 |
| 62 | FER | 0.71878341 |
| 63 | SMG1 | 0.71530261 |
| 64 | PKN2 | 0.69117246 |
| 65 | ITK | 0.68840738 |
| 66 | OXSR1 | 0.68215515 |
| 67 | LMTK2 | 0.66124292 |
| 68 | PDK1 | 0.65803727 |
| 69 | FYN | 0.63836239 |
| 70 | RET | 0.62400852 |
| 71 | LRRK2 | 0.61795827 |
| 72 | TAOK2 | 0.61427133 |
| 73 | STK39 | 0.60776958 |
| 74 | MAPK7 | 0.58402514 |
| 75 | HIPK2 | 0.54317220 |
| 76 | IKBKB | 0.53036183 |
| 77 | TNK2 | 0.52110517 |
| 78 | PDGFRB | 0.51342412 |
| 79 | TEC | 0.50024535 |
| 80 | TAOK3 | 0.49388815 |
| 81 | MAP3K6 | 0.48185261 |
| 82 | PRKCQ | 0.47975537 |
| 83 | MYLK | 0.45752570 |
| 84 | MAPK11 | 0.43916573 |
| 85 | MAP2K2 | 0.43170944 |
| 86 | MAPKAPK2 | 0.42709169 |
| 87 | CDK19 | 0.41697713 |
| 88 | MAP3K2 | 0.41387916 |
| 89 | CDK6 | 0.36071629 |
| 90 | PRKD2 | 0.35866906 |
| 91 | SRC | 0.34428964 |
| 92 | SIK1 | 0.34307477 |
| 93 | GRK5 | 0.33897919 |
| 94 | BMX | 0.33428711 |
| 95 | MAP3K12 | 0.33392407 |
| 96 | PRKCD | 0.30937580 |
| 97 | MAP2K6 | 0.30797046 |
| 98 | KDR | 0.30359178 |
| 99 | IGF1R | 0.29659375 |
| 100 | MAP3K5 | 0.29338651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.58317882 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.57525023 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.37438159 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.21195395 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.14910647 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.10886619 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66854570 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.54633622 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.45540558 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.26665572 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19690880 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15540432 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.06386203 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.01177855 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65004416 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62806158 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60136736 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.57834204 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46520541 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.45622066 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.44556349 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.41751963 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40615860 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.40340641 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37178509 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29437317 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28309025 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.27898397 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19838878 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17346757 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16905226 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16611726 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.13532152 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06573214 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05897090 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.05792434 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.04633694 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04323970 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.01343997 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99520769 |
| 41 | Measles_Homo sapiens_hsa05162 | 0.97054826 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92527813 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92331889 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92224498 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90971473 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90743976 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86002993 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.80851704 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80104081 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77232275 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74900597 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74172371 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71939441 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71319071 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69126899 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66281966 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.66126809 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.65619884 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64602090 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64570049 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64214743 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62042484 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61327773 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60372585 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60007247 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59951124 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55573074 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.51901037 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51034393 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.49499593 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.48857610 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46368188 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45463799 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.44791292 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43085157 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42872239 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41356404 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40516138 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40399026 |
| 80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39649146 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39021746 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38241160 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38017061 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36648839 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36198885 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35914306 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.34747960 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.33891231 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33541251 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32702156 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31605193 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31457634 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29303834 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28233003 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28167666 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.26881376 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.26844723 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25818489 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.25818090 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.25531326 |

